BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14242025)

  • 1. MUTAGENICITY OF A MONOFUNCTIONAL ALKYLATING AGENT DERIVATIVE OF ACRIDINE IN NEUROSPORA.
    BROCKMAN HE; GOBEN W
    Science; 1965 Feb; 147(3659):750-1. PubMed ID: 14242025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forward-mutation tests on the antitumor agent ICR-170 in Neurospora crassa demonstrate that it induces gene/point mutations in the ad-3 region and an exceptionally high frequency of multiple-locus ad-3 mutations with closely linked sites of recessive lethal damage.
    de Serres FJ; Malling HV
    Mutat Res; 1994 Oct; 310(1):15-36. PubMed ID: 7523879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and classical genetic analyses of his-3 mutants of Neurospora crassa. I. Tests for allelic complementation and specific revertibility.
    Overton LK; Dubins JS; de Serres FJ
    Mutat Res; 1989 Oct; 214(2):267-83. PubMed ID: 2529437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of N2 or O2 on two alkylating agents in Neurospora crassa.
    Seyfried TN
    Mutat Res; 1975 May; 28(2):155-62. PubMed ID: 49017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation induction by difunctional alkylating agents in Neurospora crassa.
    Ong TM; Serres FJ
    Genetics; 1975 Jul; 80(3):475-82. PubMed ID: 133852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homology tests on presumed multilocus deletions in the ad-3 region of Neurospora crassa induced by the acridine mustard ICR-170.
    De Serres FJ; Brockman HE
    Genetics; 1968 Jan; 58(1):79-83. PubMed ID: 5656345
    [No Abstract]   [Full Text] [Related]  

  • 7. Relations between complementation patterns and genetic alterations in nitrous acid-induced ad-3B mutants of Neurospora crassa.
    Malling HV; de Serres FJ
    Mutat Res; 1967; 4(4):425-40. PubMed ID: 6059024
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutagenicity of actinomycin D in Neurospora crassa.
    Fisher CR; Malling HV; De Serres FJ; Snyder S
    Mutat Res; 1975 Dec; 33(2-3):187-92. PubMed ID: 55964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of ICR-177-induced ad-3 mutants of Neurospora crassa.
    Ong T
    Mutat Res; 1970 Feb; 9(2):183-91. PubMed ID: 5413676
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutagenesis at the ad-3A and ad-3B loci in haploid UV-sensitive strains of Neurospora crassa. VI. Genetic characterization of ad-3 mutants provides evidence for qualitative differences in the spectrum of genetic alterations between wild-type and nucleotide excision-repair-deficient strains.
    de Serres FJ; Inoue H; Schüpbach ME
    Mutat Res; 1983 Mar; 108(1-3):93-108. PubMed ID: 6188039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azaguanine-resistant mutants induced by several mutagens in a neurospora heterokaryon.
    Hoffmann GR; Malling HV
    Mutat Res; 1975 Mar; 27(3):307-18. PubMed ID: 163959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of ad-3 mutants induced by AF-2 and two other nitrofurans in Neurospora crassa.
    Ong T; de Serres FJ
    Environ Mutagen; 1981; 3(2):151-8. PubMed ID: 6165577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B; de Serres FJ
    J Environ Pathol Toxicol; 1979; 2(4):1109-18. PubMed ID: 156240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxylamine-induced purple mutants (ad-3) in Neurospora crassa. II. Identification of genetic alteration at the molecular level.
    Malling HV
    Hereditas; 1971; 68(2):219-34. PubMed ID: 4281762
    [No Abstract]   [Full Text] [Related]  

  • 15. The mutagenicity of the acridine mustard (ICR-170) and the structurally related compounds in Neurospora.
    Malling HV
    Mutat Res; 1967; 4(3):265-74. PubMed ID: 6051828
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the mutagenicity and mutagen specificity of ethylenimine with triethylenemelamine in the ad-3 region of heterokaryon 12 of Neurospora crassa.
    de Serres FJ; Malling HV; Ong TM
    Mutat Res; 1995 May; 328(2):193-205. PubMed ID: 7739603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B
    J Toxicol Environ Health; 1978; 4(5-6):815-24. PubMed ID: 153406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation at the am locus of Neurospora crassa.
    Kinsey JA; Hung BS
    Genetics; 1981; 99(3-4):405-14. PubMed ID: 6177580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay of cytotoxicity and mutagenicity of alkylating agents by using Neurospora spheroplasts.
    Pope S; Baker JM; Parish JH
    Mutat Res; 1984 Jan; 125(1):43-53. PubMed ID: 6228734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. VII. Genetic lesions resulting in gene/point mutations at the ad-3B locus have different dose-response relationships.
    de Serres FJ
    Mutat Res; 1990 Oct; 232(2):115-40. PubMed ID: 2145510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.